Invention Grant
- Patent Title: Methods of treating myeloproliferative disorders
-
Application No.: US17711872Application Date: 2022-04-01
-
Publication No.: US12070464B2Publication Date: 2024-08-27
- Inventor: Adrian Senderowicz , Michael Cooper
- Applicant: Constellation Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Constellation Pharmaceuticals, Inc.
- Current Assignee: Constellation Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: McCarter & English, LLP
- Agent Michael J. DeGrazia
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61P35/00
Abstract:
The present disclosure relates to the use of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide, and pharmaceutically acceptable salts thereof, for treating myelofibrosis.
Public/Granted literature
- US20230053604A1 METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS Public/Granted day:2023-02-23
Information query
